Citation Impact
Citing Papers
Graft microvascular disease in solid organ transplantation
2014 StandoutNobel
Acute rejection and late renal transplant failure: Risk factors and prognosis
2004
Anemia and Blood Transfusion in Critically Ill Patients
2002 Standout
Increasing the Opportunity of Live Kidney Donation by Matching for Two- and Three-Way Exchanges
2006 StandoutNobel
Cadaver Donor Screening for Infectious Agents in Solid Organ Transplantation
2000
Messenger RNA-Based Vaccines Against Infectious Diseases
2020 StandoutNobel
Pre-Transplant Assessment of Donor-Reactive, HLA-Specific Antibodies in Renal Transplantation: Contraindication vs. Risk
2003
Excess iron induces hepatic oxidative stress and transforming growth factor β1 in genetic hemochromatosis
1997
Utilizing List Exchange and Nondirected Donation through ‘Chain’ Paired Kidney Donations
2006 StandoutNobel
Toxoplasma gondii infection in humans and animals in the United States
2008 Standout
Can Ebola Virus Vaccines Have Universal Immune Correlates of protection?
2018
The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak – an update on the status
2020 Standout
Interfering with hepatitis C virus RNA replication
2004 StandoutNobel
Calcineurin Inhibitor Nephrotoxicity
2009 Standout
ABO‐incompatibility in solid organ transplantation
2001
Ethics of a Paired-Kidney-Exchange Program
1997
Characterisation of infectious Ebola virus from the ongoing outbreak to guide response activities in the Democratic Republic of the Congo: a phylogenetic and in vitro analysis
2019
Pretransplant Evaluation for Infections in Donors and Recipients of Solid Organs
2001
Blood Transfusion-Induced Immunomodulation
1996
SUCCESSFUL TRANSPLANTATION OF HIGHLY SELECTED CD34+ PERIPHERAL BLOOD STEM CELLS IN A HLA-SENSITIZED PATIENT TREATED WITH IMMUNOADSORPTION ONTO PROTEIN A
2000
Preexisting Donor-Specific HLA Antibodies Predict Outcome in Kidney Transplantation
2010 Standout
Multiple myeloma: A review of the epidemiologic literature
2007
Target of Rapamycin Inhibitors (Sirolimus and Everolimus) for Primary Immunosuppression of Kidney Transplant Recipients: A Systematic Review and Meta-Analysis of Randomized Trials
2006
A new coronavirus associated with human respiratory disease in China
2020 StandoutNature
Interaction between hepatitis C virus proteins and host cell factors
2002 StandoutNobel
HEPATITIS C VIRUS AND ORGAN TRANSPLANTATION
1996
The role of complement in antibody-mediated rejection in kidney transplantation
2012
Balancing Acts
2004 Standout
Kidney and Pancreas Transplantation in the United States, 1996–2005
2007
Familial multiple myeloma: report of fifteen families
1999
Diagnosis, management, and treatment of hepatitis C: An update # † ‡
2008 Standout
Liver transplantation for chronic viral hepatitis
1995
Inflammation and tumor progression: signaling pathways and targeted intervention
2021 Standout
A role of PIEZO1 in iron metabolism in mice and humans
2021 StandoutNobel
Structures of Ebola virus GP and sGP in complex with therapeutic antibodies
2016
Immunity, Inflammation, and Cancer
2010 Standout
The CRIT Study: Anemia and blood transfusion in the critically ill—Current clinical practice in the United States*
2004 Standout
Iron in joint inflammation.
1993
A New Mouse Liver-specific Gene, Encoding a Protein Homologous to Human Antimicrobial Peptide Hepcidin, Is Overexpressed during Iron Overload
2001 Standout
LONG-TERM RESULTS OF ABO-INCOMPATIBLE LIVING KIDNEY TRANSPLANTATION
1998
Hepatitis C and renal disease: an update
2003
Stable Cytotoxic T Cell Escape Mutation in Hepatitis C Virus Is Linked to Maintenance of Viral Fitness
2008 StandoutNobel
Iron uptake mechanisms of pathogenic bacteria
1993
LONG-TERM OUTCOME AND ALLOANTIBODY PRODUCTION IN A NON-MYELOABLATIVE REGIMEN FOR INDUCTION OF RENAL ALLOGRAFT TOLERANCE1
1999
Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV
2020 Standout
Successful Renal Transplantation across Simultaneous ABO Incompatible and Positive Crossmatch Barriers
2004
Strategies to Improve Long-Term Outcomes after Renal Transplantation
2002 Standout
Review of 1027 Patients With Newly Diagnosed Multiple Myeloma
2003 Standout
ABO Incompatible Renal Transplantation Without Antibody Removal Using Conventional Immunosuppression Alone
2014
Safety of Blood Group A2-to-O Liver Transplantation
2012
Effects of chloroquine on viral infections: an old drug against today's diseases
2003 Standout
Interferons α and λ Inhibit Hepatitis C Virus Replication With Distinct Signal Transduction and Gene Regulation Kinetics
2006 StandoutNobel
Hepatitis C and liver transplantation
1995
Infection in Solid-Organ Transplant Recipients
2007 Standout
Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial
2001 Standout
ABO-incompatible kidney transplantation using both A2 and non-A2 living donors
2003
Immunosuppressive Drugs for Kidney Transplantation
2004 Standout
HLA-Mismatched Renal Transplantation without Maintenance Immunosuppression
2008 Standout
Profile of Immune Cells in Axillary Lymph Nodes Predicts Disease-Free Survival in Breast Cancer
2005
Infection in Organ-Transplant Recipients
1998 Standout
Mechanisms of transfusion‐induced immunosuppression
1990
Serum trace element levels in HIV-infected subjects
1990
Iron, Iron‐binding Proteins and Immune System Cellsa
1988
An Analysis of Blood Management in Patients Having a Total Hip or Knee Arthroplasty*
1999 Standout
Humoral Theory of Transplantation
2003
Clinical Relevance of Preformed HLA Donor-Specific Antibodies in Kidney Transplantation
2008
Chronic viral hepatitis and the management of chronic renal failure
1995
Mechanisms in the Pathogenesis of Asbestosis and Silicosis
1998 Standout
The Role of Selenium in Inflammation and Immunity: From Molecular Mechanisms to Therapeutic Opportunities
2011 Standout
Chloroquine-induced inhibition of the production of TNF, but not of IL-6, is affected by disruption of iron metabolism
1993
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
ABO-incompatible organ and bone marrow transplantation: current status.
2003
Patterns of Habitat Use among Vegetation‐Dwelling Littoral Fishes in the Atchafalaya River Basin, Louisiana
2007
2016 US lymphoid malignancy statistics by World Health Organization subtypes
2016 Standout
Therapeutic plasma exchange for desensitization prior to transplantation in ABO‐incompatible renal allografts
2009
Hepatitis C infection in the transplant recipient.
1995
Transmission of Hepatitis C Virus to Several Organ and Tissue Recipients from an Antibody-Negative Donor
2005
Special Issue: KDIGO Clinical Practice Guideline for the Care of Kidney Transplant Recipients
2009 Standout
Target of rapamycin inhibitors (TOR-I; sirolimus and everolimus) for primary immunosuppression in kidney transplant recipients
2006
ABO-incompatible organ and bone marrow transplantation: current status
2003
Kidney Exchange
2004 StandoutNobel
Vaccine innovations for emerging infectious diseases—a symposium report
2019 StandoutNobel
Alien species in fresh waters: ecological effects, interactions with other stressors, and prospects for the future
2010 Standout
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice—Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Sixth Special Issue
2013
Probiotic Bacteria as Biological Control Agents in Aquaculture
2000 Standout
Mechanism of Inhibition of Ebola Virus RNA-Dependent RNA Polymerase by Remdesivir
2019
Klebsiellaspp. as Nosocomial Pathogens: Epidemiology, Taxonomy, Typing Methods, and Pathogenicity Factors
1998 Standout
What Have We Learned from Market Design?
2008 StandoutNobel
The Immunosuppressive Aspects of Blood Transfusion
1992
2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Health Care Settings
2007 Standout
Kidney paired donation
2011 StandoutNobel
Siderophore-Based Iron Acquisition and Pathogen Control
2007 Standout
Efficient Replication of Hepatitis C Virus Genotype 1a RNAs in Cell Culture
2003 StandoutNobel
A Kidney Exchange Clearinghouse in New England
2005 StandoutNobel
Evolution and Clinical Pathologic Correlations of De Novo Donor-Specific HLA Antibody Post Kidney Transplant
2012 Standout
Characterization of Vesicular Stomatitis Virus Recombinants That Express and Incorporate High Levels of Hepatitis C Virus Glycoproteins
2002 StandoutNobel
Viral Load and Immunophenotype of Cells Obtained From Lymph Nodes by Fine Needle Aspiration as Compared with Peripheral Blood Cells in HIV-Infected Patients
1996
Phytic Acid, an Iron Chelator, Attenuates Pulmonary Inflammation and Fibrosis in Rats after Intratracheal Instillation of Asbestos
1995
HEPATITIS C INFECTION IN THE TRANSPLANT RECIPIENT
1995
Simian Immunodeficiency Virus Replicates to High Levels in Sooty Mangabeys without Inducing Disease
1998 StandoutNobel
Histologic Findings One Year After Positive Crossmatch or ABO Blood Group Incompatible Living Donor Kidney Transplantation
2006
Works of Christopher Bryan being referenced
Long-Term Survival of Kidneys Transplanted from Live A2 Donors to O and B Recipients
2007
The Immune System in Hereditary Hemochromatosis: A Quantitative and Functional Assessment of the Cellular Arm
1991
TRANSPLANTATION RATE OF THE BLOOD GROUP B WAITING LIST IS INCREASED BY USING A2 AND A2B KIDNEYS1
1998
TEN-YEAR EXPERIENCE IN TRANSPLANTATION OF A2KIDNEYS INTO B AND O RECIPIENTS1
1998
IgM antibodies identified by a DTT‐ameliorated positive crossmatch do not influence renal graft outcome but the strength of the IgM lymphocytotoxicity is associated with DR phenotype*
2001
Cooperativity Enables Non-neutralizing Antibodies to Neutralize Ebolavirus
2017
ABO blood group influences a candidate's likelihood of receiving an HLA zero antigen mismatch kidney
2004
HLA Points Assigned in Cadaveric Kidney Allocation Should Be Revisited: An Analysis of HLA Class II Molecularly Typed Patients and Donors
2003
Influence of an historically positive crossmatch on cadaveric renal transplantation
1999
Current experience with renal transplantation across the ABO barrier
1992
Clinical Utility of a Lymph Node Normal Range Obtained by Flow Cytometry
1993
Screening and confirmatory testing of cadaver organ donors for hepatitis C virus infection: A U.S. National Collaborative Study
1994
LONG-TERM GRAFT SURVIVAL IS IMPROVED IN CADAVERIC RENAL RETRANSPLANTATION BY FLOW CYTOMETRIC CROSSMATCHING1
1998
Hydrology and aquatic habitat characteristics of a riverine swamp: I. Influence of flow on water temperature and chemistry
1999
Mechanism of Binding to Ebola Virus Glycoprotein by the ZMapp, ZMAb, and MB-003 Cocktail Antibodies
2015
Thermostable erythrocyte rosette-forming lymphocytes in hereditary hemochromatosis. I. Identification in peripheral blood
1984
ABO-mismatched renal transplantation in children: a report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS) and the Midwest Organ Bank (MOB).
1998
The Immunoregulatory Nature of Iron. II. Lymphocyte Surface Marker Expression
1986
Hydrology and aquatic habitat characteristics of a riverine swamp: II. Hydrology and the occurrence of chronic hypoxia
1999
The immunoregulatory nature of iron
1983
Genetic studies in multiple myeloma 1. Association with HLA-Cw5
1983
Differential inhibition of the MLR by iron: Association with HLA phenotype
1981
Transplantation of A2 and A2B kidneys from deceased donors into B waiting list candidates increases their transplantation rate.
2004